Physician profile
William J Brown
NPI 1790784627
$6,630.74
in general payments reported to CMS, 2019-2025
22 companies · $1,544 in 2025
The $1,544 reported for 2025 was more than what 86% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,300 · 2020: $192 · 2021: $324 · 2022: $591 · 2023: $583 · 2024: $1,097 · 2025: $1,544.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,223.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,223.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intersect Ent, INC. | $1,479.67 | 2019-2021 | |
| Inspire Medical Systems, INC. | $1,424.88 | 2019-2025 | Inspire |
| Genzyme Corporation | $787.81 | 2020-2025 | |
| Optinose US, INC. | $734.17 | 2019-2025 | |
| Glaxosmithkline, LLC. | $640.90 | 2021-2025 | Nucala |
| Medtronic, INC. | $474.88 | 2024-2025 | Propel, Stealthstation S8 Platform, Nuvent |
| Regeneron Healthcare Solutions, INC. | $380.89 | 2019-2025 | Dupixent |
| Stryker Corporation | $261.74 | 2019-2024 | Scopis Ent |
| Acclarent, INC | $119.24 | 2019-2022 | |
| Integra Lifesciences Corporation | $60.98 | 2019-2025 | Inspira Air, Acclarent Aera, Relieva Spinplus Nav |
| Hikma Pharmaceuticals USA | $53.48 | 2024 | Ryaltris |
| Novartis Pharmaceuticals Corporation | $31.75 | 2019 | |
| Coopersurgical, INC. | $29.62 | 2025 | Onetrac Lx |
| Phathom Pharmaceuticals, INC. | $25.59 | 2025 | Voquezna |
| Mylan Pharmaceuticals INC. | $22.60 | 2019 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alk-Abello, INC | $21.23 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $17.16 | 2021 | |
| Mimedx Group, INC. | $16.88 | 2025 | |
| Aroa Biosurgery Incorporated | $16.32 | 2024 | |
| Kaleo, INC. | $13.64 | 2021 | |
| Smith+Nephew, INC. | $12.94 | 2023 | Halo |
| Ambu INC. | $4.37 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Brown listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.